Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Akebia Therapeutics, Inc.

NASDAQ: AKBA · Life Sciences · 5 alerts · CIK 1517022

Share price
$0.4486Close, Nov 16
Market cap
$125M
Shares outstanding
277.66MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Akebia Therapeutics, Inc. filings on SEC EDGAR ↗

8:13 AM ET 8-K
Loan & Debt

Akebia Therapeutics $140M Debt Financing with Symbiotic Capital Opportunities Holding, L.P.

Akebia Therapeutics entered into a $140 million senior secured term loan facility with Symbiotic Capital, consisting of a $60 million initial tranche and $80 million in discretionary tranches. The company used the initial proceeds to repay its existing $55 million debt facility with BlackRock (Kreos). The new facility features a 60-month interest-only period with a maturity date of November 12, 2031.

Value
$140M
Counterparty
Symbiotic Capital Opportunities Holding, L.P.
Term
5 years

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.